[HTML][HTML] The KMT2A recombinome of acute leukemias in 2023
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
The KMT2A recombinome of acute leukemias in 2023
C Meyer, P Larghero, BA Lopes, T Burmeister… - Leukemia, 2023 - research.regionh.dk
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
[HTML][HTML] The KMT2A recombinome of acute leukemias in 2023
C Meyer, P Larghero, BA Lopes, T Burmeister… - Leukemia, 2023 - ncbi.nlm.nih.gov
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
[PDF][PDF] The KMT2A recombinome of acute leukemias in 2023
Leukemia, 2023 - core.ac.uk
Chromosomal rearrangements involving the human KMT2A gene (NM_001412597. 1) are
recurrently associated with the disease phenotype of acute leukemias [1, 2]. The presence of …
recurrently associated with the disease phenotype of acute leukemias [1, 2]. The presence of …
The KMT2A recombinome of acute leukemias in 2023
C Meyer, P Larghero, B Almeida Lopes, T Burmeister… - 2023 - trepo.tuni.fi
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
The KMT2A recombinome of acute leukemias in 2023
C Meyer - 2023 - ddd.uab.cat
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
[PDF][PDF] The KMT2A recombinome of acute leukemias in 2023
2023 - academia.edu
Chromosomal rearrangements involving the human KMT2A gene (NM_001412597. 1) are
recurrently associated with the disease phenotype of acute leukemias [1, 2]. The presence of …
recurrently associated with the disease phenotype of acute leukemias [1, 2]. The presence of …
The KMT2A recombinome of acute leukemias in 2023
C Meyer, P Larghero, B Almeida Lopes, T Burmeister… - Leukemia, 2023 - zora.uzh.ch
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
[PDF][PDF] The KMT2A recombinome of acute leukemias in 2023
C Meyer, P Larghero, B Almeida Lopes, T Burmeister… - 2023 - scholar.archive.org
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
The KMT2A recombinome of acute leukemias in 2023.
C Meyer, P Larghero, T Burmeister, D Gröger, R Sutton… - Leukemia, 2023 - europepmc.org
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …
as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the …